Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China
· Delayed Price · Currency is CNY 21.32
-0.78 (-3.53%)
Apr 29, 2026, 1:45 PM CST
Hybio Pharmaceutical Market Cap
Hybio Pharmaceutical has a market cap or net worth of 19.52 billion as of April 28, 2026. Its market cap has increased by 41.12% in one year.
Market Cap
19.52B
Enterprise Value
21.33B
Revenue
898.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.32
Market Cap Chart
Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 19.52B, an increase of 566.20%. That is a compound annual growth rate of 13.41%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wedge Industrial | 19.86B |
| Joincare Pharmaceutical Group Industry | 19.42B |
| Walvax Biotechnology | 19.00B |
| Betta Pharmaceuticals | 20.79B |
| Jilin Aodong Pharmaceutical Group | 20.86B |
| Tonghua Dongbao Pharmaceutical | 18.68B |
| Apeloa Pharmaceutical Co.,Ltd | 21.16B |
| China Resources Double-Crane Pharmaceutical | 18.48B |